Prospect Financial Services LLC Acurx Pharmaceuticals, Inc. Transaction History
Prospect Financial Services LLC
- $180 Billion
- Q1 2025
A detailed history of Prospect Financial Services LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Prospect Financial Services LLC holds 366,576 shares of ACXP stock, worth $230,942. This represents 0.08% of its overall portfolio holdings.
Number of Shares
366,576
Previous 329,076
11.4%
Holding current value
$230,942
Previous $268 Million
46.63%
% of portfolio
0.08%
Previous 0.15%
Shares
6 transactions
Others Institutions Holding ACXP
# of Institutions
27Shares Held
3.49MCall Options Held
100Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ2.04MShares$1.29 Million6.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA529KShares$333,4890.0% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$108,0360.0% of portfolio
-
Morgan Stanley New York, NY106KShares$66,9060.0% of portfolio
-
Vanguard Capital Wealth Advisors67.5KShares$42,5250.03% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $7.28M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...